USPTO trademark

SEMNUR PHARMACEUTICALS

Under examinationUSPTOWord markClass 5

"SEMNUR PHARMACEUTICALS" is a word mark owned by Semnur Pharmaceuticals, Inc., filed at the USPTO on December 22, 2022. It is under examination and covers class 5 (Pharmaceuticals).

View Semnur Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
SEMNUR PHARMACEUTICALS trademark as filed
As filed with the USPTO
Status
Under examination
Since October 1, 2026
Filed
December 22, 2022
Registered
Not yet
Expires
Not recorded
Application no.
97729580
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns SEMNUR PHARMACEUTICALS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Semnur Pharmaceuticals, Inc.

SMNR · Palo Alto, United States

6 trademarks in the portfolioView company

Representative

Katherine M. Basile

Reed Smith LLP

Goods and services

What the mark covers

The products and services SEMNUR PHARMACEUTICALS is filed for, grouped by Nice class.

  • Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, lumbosacral radicular pain and sciatica; pharmaceutical preparations, namely, dexamethasone sodium phosphate for medical use for use in the treatment of pain; pharmaceutical preparations, namely, dexamethasone sodium phosphate gel for medical use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Sou extension received with teas petition
  2. Notice of revival - e-mailed
  3. Petition to revive-granted
  4. Teas petition to revive received
  5. Abandonment notice e-mailed - no use statement filed
  6. Abandonment - no use statement filed
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Applicant/correspondence changes (non-responsive) entered

10 earlier steps on the official record.

FAQ

About SEMNUR PHARMACEUTICALS

Who owns the trademark "SEMNUR PHARMACEUTICALS"?

The USPTO trademark "SEMNUR PHARMACEUTICALS" (application 97729580) is owned by Semnur Pharmaceuticals, Inc.

What is the status of "SEMNUR PHARMACEUTICALS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SEMNUR PHARMACEUTICALS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b3a-cf29-759d-a3a2-4282eb26e125
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b3a-cf29-759d-a3a2-4282eb26e125",
  "object": "trademark",
  "mark_text": "SEMNUR PHARMACEUTICALS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "97729580",
  "filing_date": "2022-12-22",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Semnur Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70a-3c6e-70db-a827-2ce46a8ce1ef"
    }
  ]
}